Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abivax, Atea, Avadel, Avrobio, Cour, Dicerna, Edesa, Eli Lilly, Entasis, Galera, Harbour, Immune, Immunitybio, Inhibikase, Iterion, Noxxon, Ono, Opthea, Paratek, Pharnext, Seal Rock, Sifi, Small, Statera, Ultragenyx, Vyne.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: 60 Degrees, Adlai Nortye, Advaccine, Akeso, Apeiron, Arcturus, Ascletis, Astellas, Astrazeneca, Gan & Lee, I-Mab, Inflarx, Inovio, Medigen Vaccine Biologics, Neurobo, Oncolytics, RDIF, Reistone, Resverlogix, TC Biopharm, Westvac.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Curebase, Checkable Medical.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alphamab, Applied Therapeutics, Avelas, Biogen, Biomx, Bioxcel, Blade, Cardiol, Homology, Logicbio, Mesoblast, Moleculin, Nervgen, Oryzon, Phathom, Radius, Valneva.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Inari Medical, Intuitive Surgical, Masimo.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akeso, Astrazeneca, Eli Lilly, Medigen, Merck, Protalix, RDIF, TG.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Otsuka Medical Devices, Recor Medical.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: 60 Degrees, Alimera, Anavex, Apnimed, Atara, Biogen, BMS, Brainstorm, Crispr, EMD, Eyepoint, Faraday, First Wave, Genentech, Horizon, I-Mab, Immune-Onc, Immunitybio, Neoimmunetech, Neurobo, Oncolytics, Oryzon, Outlook, Resverlogix, Rhizen, Sanofi, Smart Immune, TC, Tizona, Ultimovacs, Union, VBI, Veru, Vistagen.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Imbed, Veracyte.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Advaccine, Aerie, Agenus, Apeiron, Arcturus, Ascletis, Astellas, BMS, Inflarx, Inhibrx, Inovio, Istari, Otonomy, Vtv.